Table 1.
Demographic and clinical data on 112 patients with stroke
| 90‐day mortality | 90‐day RANK | |||||
|---|---|---|---|---|---|---|
| Variables | Yes (n = 29) | No (n = 83) | P value | 0‐2 (n = 57) | 3‐6 (n = 55) | P value |
| Age, (years) | 75.0 (60.0‐85.0) | 67.0 (60.0‐79.0) | .07 | 67.0 (60.0‐78.5) | 72.0 (60.0‐83.0) | .09 |
| Male, n (%) | 14 (48.3) | 44 (53.0) | .82 | 31 (54.4) | 27 (49.1) | .71 |
| Stroke subtype | .62 | .39 | ||||
| Ischemic stroke | 23 (79.3) | 71 (85.5) | 50 (87.7) | 44 (80.0) | ||
| Others | 6 (20.7) | 12 (14.5) | 7 (12.3) | 11(20.0) | ||
| Entrance NIHSS | 17.5 (7.3‐23.8) | 4.0 (2.0‐10.3) | <.001 | 3.0 (2.0‐7.0) | 13.0 (5.0‐22.0) | <.001 |
| Previous mRs | 0 (0‐2) | 0 (0‐0) | .01 | 0 (0‐0) | 0 (0–2) | <.001 |
| Hypertension, n (%) | 22 (75.9) | 60 (72.3) | .95 | 42 (73.7) | 40 (72.7) | .91 |
| Diabetes, n (%) | 6 (20.7) | 17 (20.5) | .82 | 11 (19.3) | 12 (21.8) | .92 |
| Smokers, n (%) | 7 (24.1) | 30 (36.1) | .30 | 20 (35.1) | 17 (30.9) | .79 |
| Atrial fibrillation, n (%) | 7 (24.1) | 10 (12.0) | .23 | 6 (10.5) | 11 (20.0) | .26 |
| CAD, n (%) | 2 (6.9) | 10 (12.0) | .65 | 5 (8.8) | 7 (12.7) | .71 |
| CK, (U/L) | 87.0 (49.5‐178.5) | 74.0 (47.0‐124.0) | .30 | 70.5 (40.3‐120.0) | 83.0 (54.0‐180.0) | .16 |
| CK‐MB, (U/L) | 23.0 (16.0‐34.5) | 17.0 (11.0‐25.0) | .009 | 16.0 (10.0‐23.0) | 21.5 (14.5‐31.8) | .004 |
| Troponin, (μg/L) | 0.01 (0.01‐0.06) | 0.01 (0.01‐0.01) | .001 | 0.01 (0.01–0.01) | 0.01 (0.01‐0.01) | .03 |
| ECG abnormalities, n (%) | 21 (72.4) | 40 (48.2) | .03 | 22 (38.6) | 39 (70.9) | .001 |
| Stroke thrombolysis, n (%) | 7 (24.1) | 7 (8.4) | .06 | 7 (12.3) | 7 (12.7) | .83 |
Note: Data are expressed as the median (including the lower and upper quartiles) or percentages.
Abbreviations: CAD, coronary artery disease; mRs, modified Rankin scale; NIHSS, National Institute of Health Stroke Scale.